“At Popper and Company, we are excited to be bringing our deep industry expertise to Eaton Square and we look forward to helping grow the firm’s presence in life sciences and med-tech in the U.S. and globally,” Ken Walz, Partner and Principal
BALTIMORE (PRWEB) May 19, 2020
Eaton Square is pleased to announce its growth on the East Coast of the US with the addition of Popper and Company, a biotechnology and medical technology-focused strategy and M&A advisory firm.
This is an important step for Eaton Square as it continues to grow in the United States, linking US and Asia Pacific healthcare innovators with capital and investors.
Popper and Company, founded in 2003 by Caroline Popper, MD and Ken Walz, helps clients in clinical diagnostics, medical devices, life science tools, and digital health, providing guidance on a variety of commercialization challenges.
The biotechnology and life sciences sector is key to Eaton Square’s continued growth as a cross-border M&A and capital services firm. Given the current global environment, biotechnology is predicted to continue to be extremely active in M&A activity driven by initiatives from large global and regional pharmaceutical companies.
“Eaton Square is focused on assisting clients to grow across the US and internationally. We believe the combination of Popper and Company with our existing Life Sciences and Healthcare capabilities significantly enhances our ability to assist clients in the US and Asia Pacific to undertake transactions and attract capital globally.” Nick Weston, Managing Principal, Eaton Square.
“We are looking forward to initiating global and regional cross-border solutions for pharma, biotech and med-tech sectors. These now include M&A, debt and equity solutions, strategy and advisory. This will give Eaton Square a strong biotech, healthcare, device and A.I. presence in the US and Asia Pacific,” Bob Atwill, Eaton Square Principal.
“At Popper and Company, we are excited to be bringing our deep industry expertise to Eaton Square and we look forward to helping grow the firm’s presence in life sciences and med-tech in the U.S. and globally,” Ken Walz, Eaton Square Principal.
“I am excited to welcome the Popper and Company team to enable us to service more clients looking to grow in the healthcare space. Their presence in the Baltimore/DC area will also strengthen our presence in the East Coast of the United States,” Reece Adnams, Eaton Square CEO.
Joining the Eaton Square Biotech team are:
Ken Walz has worked for more than 25 years in the biotech, diagnostics, and medical device industries in business development and finance roles and is particularly interested in the application of disruptive technologies to address inefficiencies in the healthcare system. He brings broad experience in commercial operations and strategy development and has extensive experience leading transaction processes. At Popper and Company, he assists clients in all aspects of strategy and corporate development including strategic partnership development, transaction process management, and health economic modeling.
Prior to Popper and Company, Ken held senior positions at MDS Proteomics and Becton Dickinson. Ken holds a BA in Economics from the University of Maryland Baltimore County and an MS in Finance from Loyola College of Maryland.
Caroline Popper, MD
Caroline is a physician with more than 25 years of hands-on operating experience within health care companies. She has managed a wide spectrum of diagnostics, device and drug discovery businesses in both Fortune 500 and start-up settings, at amongst others, Becton Dickinson, bioMerieux, and MDS. She co-founded Popper and Company with Ken Walz specifically to bring integrated strategic and operational expertise to healthcare clients. She earned her medical degree at the University of the Witwatersrand, South Africa and completed post-graduate training in internal medicine and pathologist at Johns Hopkins in Baltimore. She also trained in Health Policy and Health Economics at the Johns Hopkins Bloomberg School of Public Health.
Eaton Square, a cross-border M&A and capital services firm, now has a total of 19 offices across the US, Canada, China & Hong Kong, Australia, New Zealand, UK, Switzerland, Singapore and Israel.
If you would like to arrange a time to speak with our Life Sciences and Healthcare team, please contact them at:
Ken Walz – email@example.com
Caroline Popper – firstname.lastname@example.org
Bob Atwill – email@example.com
Nick Weston – firstname.lastname@example.org
Reece Adnams – email@example.com